{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:19:12Z","timestamp":1788200352838,"version":"build-2803163510"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Therapy"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/dth.12370","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T07:18:30Z","timestamp":1466061510000},"page":"377-384","source":"Crossref","is-referenced-by-count":52,"title":["The use of oral antibiotics in treating acne vulgaris: a new approach"],"prefix":"10.1155","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-9861","authenticated-orcid":false,"given":"Georgia","family":"Farrah","sequence":"first","affiliation":[{"name":"Resident Medical Officer, Sir Charles Gairdner Hospital; Perth Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Tan","sequence":"additional","affiliation":[{"name":"Consultant Dermatologist, Dermatology Department; Sir Charles Gairdner Hospital; Perth Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"issue":"9813","key":"10.1111\/dth.12370-BIB0001|dth12370-cit-0001","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams","year":"2012","journal-title":"Lancet"},{"issue":"5, Suppl. 1","key":"10.1111\/dth.12370-BIB0002|dth12370-cit-0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne Group","volume":"60","author":"Thiboutot","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1111\/dth.12370-BIB0003|dth12370-cit-0003","first-page":"655","article-title":"The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review","volume":"9","author":"Patel","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"8","key":"10.1111\/dth.12370-BIB0004|dth12370-cit-0004","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1517\/14656566.2011.553192","article-title":"Treating acne with antibiotic-resistant bacterial colonization","volume":"12","author":"Tzellos","year":"2011","journal-title":"Exp Opin Pharmacother"},{"issue":"1","key":"10.1111\/dth.12370-BIB0005|dth12370-cit-0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1529-8019.2012.01497.x","article-title":"New antibiotic therapies for acne and rosacea","volume":"25","author":"Mays","year":"2012","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1111\/dth.12370-BIB0006|dth12370-cit-0006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/11632500-000000000-00000","article-title":"Newer approaches to the treatment of acne vulgaris","volume":"13","author":"Simonart","year":"2012","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1111\/dth.12370-BIB0007|dth12370-cit-0007","first-page":"581","article-title":"Efficacy and safety of subantimicrobial dose, modified-release doxycycline 40 mg versus doxycycline 100 mg versus placebo for the treatment of inflammatory lesions in moderate and severe acne: a randomized, double-blinded, controlled study","volume":"14","author":"Moore","year":"2015","journal-title":"J Drug Dermatol"},{"issue":"5","key":"10.1111\/dth.12370-BIB0008|dth12370-cit-0008","first-page":"22","article-title":"In-vivo effectiveness of adapalene 0.1%\/benzoyl peroxide 2.5% gel on antibiotic-sensitive and resistant propionibacterium acnes","volume":"4","author":"Leyden","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"10.1111\/dth.12370-BIB0009|dth12370-cit-0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1684\/ejd.2014.2309","article-title":"Antibiotic stewardship in dermatology: limiting antibiotic use in acne","volume":"24","author":"Dreno","year":"2014","journal-title":"Eur J Dermatol"},{"issue":"Suppl. 4","key":"10.1111\/dth.12370-BIB0010|dth12370-cit-0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.13190","article-title":"Understanding innate immunity and inflammation in acne: implications for management","volume":"29","author":"Dreno","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/dth.12370-BIB0011|dth12370-cit-0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","article-title":"European evidence-based (S3) guidelines for the treatment of acne","volume":"26","author":"Nast","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1111\/dth.12370-BIB0012|dth12370-cit-0012","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1111\/dth.12370-BIB0013|dth12370-cit-0013","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"S1","key":"10.1111\/dth.12370-BIB0014|dth12370-cit-0014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjd.13639","article-title":"Management of severe acne","volume":"172","author":"Zouboulis","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1111\/dth.12370-BIB0015|dth12370-cit-0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.phrs.2010.10.007","article-title":"Clinical applications of non-antimicrobial tetracyclines in dermatology","volume":"63","author":"Monk","year":"2011","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1111\/dth.12370-BIB0016|dth12370-cit-0016","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/ajd.12075","article-title":"Non-antibiotic properties of tetracyclines and their clinical application in dermatology","volume":"55","author":"Perret","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1111\/dth.12370-BIB0017|dth12370-cit-0017","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaad.2014.02.031","article-title":"A retrospective analysis of the duration of oral antibiotic therapy for the treatment of acne among adolescents: investigating practice gaps and potential cost-savings","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/dth.12370-BIB0018|dth12370-cit-0018","first-page":"1","article-title":"Minocycline for acne vulgaris: efficacy and safety","volume":"8","author":"Garner","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1111\/dth.12370-BIB0019|dth12370-cit-0019","first-page":"1407","article-title":"Doxycycline and minocycline for the management of acne: a review of efficacy and safety with emphasis on clinical implications","volume":"9","author":"Kircik","year":"2010","journal-title":"J Drug Dermatol"},{"issue":"2","key":"10.1111\/dth.12370-BIB0020|dth12370-cit-0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1440-0960.2011.00867.x","article-title":"Propionibacterium acnes (P. acnes) resistance and antibiotic use in patients attending Australian general practice","volume":"53","author":"Toyne","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"5","key":"10.1111\/dth.12370-BIB0021|dth12370-cit-0021","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaad.2015.01.048","article-title":"Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings","volume":"72","author":"Straight","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/dth.12370-BIB0022|dth12370-cit-0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"issue":"12","key":"10.1111\/dth.12370-BIB0023|dth12370-cit-0023","first-page":"1149","article-title":"Subantimicrobial-dose doxycycline in the treatment of moderate facial acne","volume":"7","author":"Toossi","year":"2008","journal-title":"J Drug Dermatol"},{"issue":"6","key":"10.1111\/dth.12370-BIB0024|dth12370-cit-0024","first-page":"658","article-title":"A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium","volume":"12","author":"Leyden","year":"2013","journal-title":"J Drug Dermatol"},{"issue":"6","key":"10.1111\/dth.12370-BIB0025|dth12370-cit-0025","first-page":"667","article-title":"Harnessing the anti-inflammatory effects of topical dapsone for management of acne","volume":"9","author":"Kircik","year":"2010","journal-title":"J Drug Dermatol"},{"issue":"4","key":"10.1111\/dth.12370-BIB0026|dth12370-cit-0026","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00128071-200910040-00002","article-title":"Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris","volume":"10","author":"Stotland","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"9","key":"10.1111\/dth.12370-BIB0027|dth12370-cit-0027","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1517\/14656560903002097","article-title":"An evaluation of dapsone gel 5% in the treatment of acne vulgaris","volume":"10","author":"Pickert","year":"2009","journal-title":"Exp Opin Pharmacother"},{"issue":"2","key":"10.1111\/dth.12370-BIB0028|dth12370-cit-0028","first-page":"191","article-title":"Use of dapsone 5% gel as maintenance treatment of acne vulgaris following completion of oral doxycycline and dapsone 5% gel combination treatment","volume":"15","author":"Kircik","year":"2016","journal-title":"J Drug Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fdth.12370","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/dth.12370\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:56:03Z","timestamp":1671818163000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dth.12370"}},"subtitle":["Oral antibiotics for acne vulgaris: a new approach"],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1111\/dth.12370","archive":["Portico"],"relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}